abstract |
THE INVENTION REFERS TO NEW COMPOUNDS OF 3 - DESCLADINOSA 2,3 - ANHYDROETHRITROMYCIN AND SALES AND ESTERES PHARMACEUTICALLY ACCEPTABLE OF THE SAME, WHICH PRESENT ANTIBACTERIAL ACTIVITY, SELECTED FROM THE GROUP FORMED BY (()) II), (C) (III), Y (D) (IV). PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOSITE OF FORMULAS (I) - (IV) OF THE INVENTION ARE DESCRIBED, IN COMBINATION WITH A PHARMACEUTICALLY ACCEPTABLE EXCIPIENT, AS WELL AS AN ADMINISTRATION PROCESSING PROCEDURE OF A PHARMACEUTICAL COMPOSITION CONTAINING A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOSITE OF FORMULAS (I) (IV) OF THE INVENTION. |